Comparative Pharmacology
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus SODIUM CHLORIDE 0 9 AND POTASSIUM CHLORIDE 0 075 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus SODIUM CHLORIDE 0 9 AND POTASSIUM CHLORIDE 0 075 IN PLASTIC CONTAINER.
MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER vs SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Magnesium sulfate provides magnesium ions, which are essential for various physiological processes. It acts as a cofactor for enzymatic reactions, stabilizes excitable membranes, and antagonizes calcium entry at the neuromuscular junction, leading to reduced acetylcholine release and muscle relaxation. In the CNS, it may act as a noncompetitive antagonist of NMDA receptors, exerting anticonvulsant effects.
Sodium chloride 0.9% and potassium chloride 0.075% solution provides electrolyte replacement to maintain fluid and electrolyte balance. Sodium is the principal cation of extracellular fluid and maintains osmotic pressure and acid-base balance. Potassium is the principal intracellular cation and is essential for nerve impulse transmission, muscle contraction, and enzymatic reactions.
1 to 4 g intravenously as a 5% to 20% solution, rate not exceeding 150 mg/min; dosing frequency depends on indication (e.g., preeclampsia/eclampsia: 4-5 g IV loading then 1-2 g/hr infusion; hypomagnesemia: 1-2 g IV over 1-2 hours, may repeat based on serum magnesium levels).
Intravenous infusion: 500-1000 mL as a single dose; rate determined by clinical needs, typically 2-4 mL/min. Maximum infusion rate 20 mEq K+/hour.
None Documented
None Documented
Terminal half-life approximately 4-5 hours in normal renal function; prolonged in renal impairment (up to 40 hours).
Sodium and potassium ions have distribution half-lives of ~20-30 minutes; elimination half-life is not applicable as they are freely filtered and reabsorbed to maintain homeostasis. Clinical context: Kinetics depend on renal function and hydration status.
Primarily renal (90-100% as unchanged magnesium). Less than 1% biliary/fecal.
Renal: >95% of infused sodium and potassium ions are excreted unchanged in urine. Fecal and biliary routes are negligible (<5%).
Category C
Category A/B
Electrolyte
Electrolyte